Insider trades

Philip Wagenheim, Director of Immunome IMNM, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $1.3M. The latest trade was on 06/10.

Philip Wagenheim

Director
First filing
23/01/17
Trades
9 trades
Buys / sales
0 / 2
12-month net buying
−$1.3M
Last trade
06/10

Trading activity

Transactions

Trade type
IMNM
Open-market sale03/20–03/2303/2365,000 sh2 trades$20.55avg.$1,335,626−16.0%